Autres langues OncoSil Medical Limited

Actions

OSL

AU000000OSL3

Temps Différé Australian S.E. Autres places de cotation 02:32:51 08/05/2024			Varia. 5j.	Varia. 1 janv.
0,0045 ^AUD	0,00%		-10,00%	-50,00%

20/03	Oncosil Medical va lever plus de 7 millions de dollars australiens par le biais d'un placement et d'une offre de droits.	MT
28/02	OncoSil Medical Limited annonce ses résultats pour le semestre clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

OncoSil Medical Raises AU$5.3 Million under Entitlement Offer	02/05
OncoSil Medical Treats Two More Patients in Netherlands in Pancreatic Cancer Trial	18/04
OncoSil Medical Treats First Commercial Patient in Turkey with Implantable Pancreatic Cancer Device	16/04
OncoSil Medical Treats First UK Patient for Pancreatic Cancer Study	12/04
OncoSil Medical Obtains Device Reimbursement Approval in UK	09/04
First Austria-Based Patients Treated Using OncoSil Pancreatic Cancer Device	05/04
Oncosil Medical Issues Non-Renounceable Entitlement Offer Prospectus	25/03
Oncosil Medical to Raise Over AU$7 Million via Placement, Entitlement Offer	20/03
OncoSil Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Australian Shares End Eight-Day Winning Streak as Early US Fed Rate Cut Hopes Fade	01/02
OncoSil Device Included in German Funding Program Negotiations; Shares Jump 14%	01/02
OncoSil Strikes Exclusive Distribution Deal For Turkish Market; Shares Jump 14%	01/02
OncoSil Medical Receives AU$1.1 Million R&D Tax Rebate	15/12
First Patient Treated in OncoSil Medical's Pancreatic Cancer Drug Trial	29/11
Oncosil Medical Limited Elects Gabrielle Liberatore as Director	29/11
Australian Shares Rise on Expectations of Easing October CPI	24/11
OncoSil Medical Secures Insurer Clearance for Pancreatic Cancer Device in Israel	24/11
OncoSil Medical Limited Announces Retirement of Brian Leedman from the Board	18/09/23
OncoSil Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Oncosil Medical Limited Announces Change of Principal Place of Business	16/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues OncoSil Medical Limited

Actions

OSL

AU000000OSL3

Autres langues

Filtres